PMC:7544934 / 15411-16177
Annnotations
LitCovid_Glycan-Motif-Structure
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T41 | 4-7 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
T42 | 4-7 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
T43 | 336-339 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
T44 | 336-339 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
T45 | 579-582 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
T46 | 579-582 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
T47 | 762-765 | https://glytoucan.org/Structures/Glycans/G00057MO | denotes | LDN |
T48 | 762-765 | https://glytoucan.org/Structures/Glycans/G31736BK | denotes | LDN |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
342 | 135-139 | Gene | denotes | il-6 | Gene:16193 |
343 | 144-148 | Gene | denotes | Il1b | Gene:16176 |
344 | 225-229 | Gene | denotes | IL-6 | Gene:16193 |
345 | 234-239 | Gene | denotes | IL-1β | Gene:16175 |
346 | 376-381 | Gene | denotes | IL-1β | Gene:16175 |
347 | 393-397 | Gene | denotes | IL-6 | Gene:16193 |
348 | 619-626 | Gene | denotes | insulin | Gene:3630 |
349 | 672-678 | Gene | denotes | ERK1/2 | Gene:5595 |
350 | 153-159 | Species | denotes | murine | Tax:10090 |
351 | 282-288 | Species | denotes | murine | Tax:10090 |
352 | 430-434 | Species | denotes | mice | Tax:10090 |
353 | 695-698 | CellLine | denotes | RAW | CVCL:F681 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T120 | 436-671 | Sentence | denotes | Values are expressed as mean ± SEM (n = 3) from three independent sets of repeats (mean ± SEM ***p < 0.001, **p, ^^p < 0.01 *p,^p < 0.05.) (D) LDN acts as EKR1 inhibitor and improved insulin sensitivity in LPS treated macrophage cells. |
T121 | 672-766 | Sentence | denotes | ERK1/2 (Immunoblot) in RAW cells treated with LPS (1ug/ml) in the presence and absence of LDN. |